LRMR short interest
Larimar Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 15,369,771 |
|---|---|
| Change vs prior report | 1,475,465 (+10.6%) |
| Change over six months | +101.2% |
| Days to cover | 8.70 (sector: 3.78) |
| Average daily volume | 1,767,337 |
| Rank in Healthcare | #168 of 922 by days to cover |
LRMR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 15,369,771 | +10.6% | 8.70 | 1,767,337 |
| 2026-09-15 | 13,894,306 | +1.3% | 14.89 | 932,915 |
| 2026-08-31 | 13,721,861 | +2.1% | 15.33 | 895,151 |
| 2026-08-14 | 13,443,456 | +10.3% | 11.23 | 1,196,769 |
| 2026-07-31 | 12,190,367 | +7.8% | 9.38 | 1,299,572 |
| 2026-07-15 | 11,303,953 | -7.3% | 4.89 | 2,310,404 |
| 2026-06-30 | 12,193,251 | +15.7% | 3.18 | 3,837,640 |
| 2026-06-15 | 10,535,603 | +30.9% | 5.06 | 2,080,723 |
| 2026-05-29 | 8,046,494 | -8.0% | 5.28 | 1,523,753 |
| 2026-05-15 | 8,744,601 | +5.2% | 4.32 | 2,025,677 |
| 2026-04-30 | 8,309,598 | +13.3% | 7.01 | 1,184,563 |
| 2026-04-15 | 7,332,588 | -4.0% | 4.97 | 1,474,748 |
| 2026-03-31 | 7,639,333 | +5.3% | 3.89 | 1,963,239 |
| 2026-03-13 | 7,255,138 | -5.7% | 2.69 | 2,692,324 |
| 2026-02-27 | 7,692,689 | -14.3% | 1.00 | 13,246,649 |
| 2026-02-13 | 8,977,079 | +2.4% | 10.63 | 844,140 |
| 2026-01-30 | 8,765,467 | +2.1% | 6.26 | 1,400,998 |
| 2026-01-15 | 8,588,537 | +4.2% | 7.61 | 1,129,121 |
| 2025-12-31 | 8,240,719 | +4.0% | 6.98 | 1,180,422 |
| 2025-12-15 | 7,922,334 | -19.2% | 5.83 | 1,359,308 |
| 2025-11-28 | 9,804,662 | -2.7% | 6.57 | 1,491,415 |
| 2025-11-14 | 10,075,712 | +10.7% | 5.85 | 1,720,891 |
| 2025-10-31 | 9,103,944 | +3.3% | 6.02 | 1,511,713 |
| 2025-10-15 | 8,816,753 | -1.4% | 2.08 | 4,233,686 |
| 2025-09-30 | 8,944,347 | +16.9% | 1.80 | 4,969,145 |
import finzdata as yf
yf.Ticker("LRMR").short_interest # every report since 2017
yf.Client().short_interest(["LRMR"], start="2018-01-01")Healthcare short interest · LRMR price history · Who owns LRMR · All short interest